Seeking men and women aged 18-60 for a study of an investigational drug for non-relapsing secondary progressive multiple sclerosis.
Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine). Participants are twice as likely to get the investigational drug than the placebo.
What we're hoping for
We are studying whether an investigational drug taken as a tablet by mouth daily is safe and effective in preventing brain lesions for people with non-relapsing secondary progressive multiple sclerosis .
ClinicalTrials.gov Identifier: NCT04411641